YAP1 and prostate carcinoma: Interestingly, a similar mechanism appears to be shared by another hormone receptor, androgen receptor (AR), as elevated nuclear YAP has been found to disrupt the TEAD-AR interaction and inhibit AR’s transcriptional activity, thereby acting as a context-dependent tumor suppressor in AR+ prostate cancer [250].